Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research
Abstract Despite introduction of biological disease modifying anti-rheumatic drugs (DMARDs) for Rheumatoid arthritis (RA) treatment, therapeutic strategies do not always lead to disease control and remission. Hence, a more efficient patient stratification and monitoring biomarkers and tools are need...
Main Authors: | Celia Cartagena García, Nathalie Balandraud, Jean Roudier, Pierre Lafforgue, Nathalie Lambert, Jean-Marc Busnel |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-16622-4 |
Similar Items
-
In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope
by: Guillaume Larid, et al.
Published: (2021-06-01) -
Biomarkers in psoriatic arthritis: A meta-analysis and systematic review
by: Theo Wirth, et al.
Published: (2022-11-01) -
How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model
by: Jean Roudier, et al.
Published: (2022-06-01) -
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis.
by: Nathalie Balandraud, et al.
Published: (2013-01-01) -
A whole blood-based functional assay to characterize immunoglobulin A effector functions
by: Alice Bacon, et al.
Published: (2024-12-01)